فرآورده‌های‌ تزریقی‌ ایران‌

دفرا | Stocks - Tehran Stock Exchange (TSE)

داروهای شیمیایی و گیاهی

Sector:

Market Type:

Status:

Last Price: - 0.00

Close Price: -

	2026/06/22 Fiscal Year 2026/03/2012 Month	2025/12/06 Fiscal Year 2025/03/1912 Month	2025/06/23 Fiscal Year 2025/03/2012 Month
Net Profit to Sales	60.79	-	58.95
Gross Profit to Sales	72.85	-	68.41
Operating Margin	70.36	-	66.79
Gross Profit to Sales	72.72	-	71.05
Net Profit to Gross Profit	83.61	-	82.98
Return on Assets (ROA)	53.61	-	50.94
Return on Capital (%)	273.09	-	305.93
Return on Equity (ROE)	71.85	-	72.31
Working Capital Return	131.6	-	112.66
Fixed Asset Return	640.37	-	293.29
Loan Benefit Assessment	1.34	-	1.42
Current Ratio	2.85	2.82	2.82
Quick Ratio	2.49	2.5	2.5
Liquidity Ratio	0.26	0.17	0.17
Net Working Capital	14,526,584	7,603,313	7,603,433
Current Assets Ratio	0.63	0.7	0.7
Inventory Turnover	88.05	-	115.34
Receivables Collection Period	197.25	-	240.56
Inventory to Working Capital	0.19	0.17	0.17
Working Capital Turnover	2.16	-	1.91
Fixed Asset Turnover	10.53	-	4.98
Total Asset Turnover	0.88	-	0.86
Debt Ratio	0.25	0.3	0.3
Debt to Equity	0.34	0.42	0.42
Long-Term Debt to Equity	0.04	0.07	0.07
Current Debt to Equity	0.3	0.35	0.35
Equity Ratio	74.62	70.45	70.45
Debt Coverage Ratio	2.54	3.7	3.7

At a Glance